Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervi... (women annually andafter breast cancer is...)

Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer

Date:11/19/2008

women annually and, after breast cancer, is the second-most-common malignancy found in women. Cervical cancer is caused by "high-risk" types of the human papillomavirus (HPV). It's estimated that 80 percent of women will get an HPV infection at some point in their lives. However, in most cases, the infection goes away or is suppressed by the body without causing problems. It is only infections that persist that can cause abnormal cells to form that may develop into cervical cancer if not detected and treated early. In Mexico, current estimates from the World Health Organization indicate that 12,516 women are diagnosed with cervical cancer every year, and 5,777 die from the disease.

About QIAGEN (qiagen.com)

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 2,900 people in over 30 locations worldwide.

Certain of the statements contained in this news release may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Ex
'/>"/>

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Neogen Forms Mexican Subsidiary
2. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
3. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
4. CHS Receives Prestigious Honor from Department of Defense
5. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
6. HHS Issues First Department-Wide Report on Personalized Health Care
7. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
8. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
9. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
10. BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department
11. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software

Post Your Comments:

Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervi...(women annually andafter breast cancer is...)